Key terms
About CVS
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CVS news
Yesterday
5:38am ET
Buy Rating Affirmed: CVS Health’s Proactive Strategies Counter Medicare Advantage Pressures and Unlock Growth Opportunities
May 14
11:01am ET
CVS Health: Core trends ‘very consistent’ with 2023
May 14
4:37am ET
Market Perform Rating on CVS Amid EPS Guidance Downgrade and Medicare Uncertainty
May 13
2:25pm ET
CVS Health call volume above normal and directionally bullish
May 09
4:35am ET
Argus Research Sticks to Its Buy Rating for CVS Health (CVS)
May 08
10:30pm ET
Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
May 08
10:04am ET
CVS Health price target lowered to $80 from $100 at Argus
May 07
7:58am ET
CVS Health’s Financial Challenges Prompt Conservative Outlook and Adjusted Guidance
May 03
1:41am ET
SPY ETF Update, 5/3/2024
May 02
3:46pm ET
CVS Health downgraded to Hold from Buy at HSBC
May 02
9:45am ET
Carvana upgraded, Block downgraded: Wall Street’s top analyst calls
May 02
9:35am ET
CVS Health price target lowered to $66 from $90 at Truist
May 02
9:20am ET
Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and SurModics (SRDX)
May 02
9:01am ET
CVS Health price target lowered to $65 from $85 at Raymond James
May 02
8:10am ET
CVS Health (CVS) Receives a Rating Update from a Top Analyst
May 02
8:03am ET
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Cross Country Healthcare (CCRN) and CVS Health (CVS)
May 02
7:44am ET
CVS Health price target lowered to $77 from $95 at BofA
May 02
6:34am ET
RBC Capital Remains a Buy on CVS Health (CVS)
May 02
5:46am ET
CVS Health price target lowered to $63 from $78 at Barclays
May 02
5:19am ET
CVS Health Hold Rating Justified by Guidance Reduction and Uncertain Cost Trends
May 02
4:45am ET
CVS Health downgraded to Neutral from Buy at UBS
May 02
3:50am ET
Barclays Keeps Their Hold Rating on CVS Health (CVS)
May 01
1:48pm ET
Cantor downgrades CVS Health to Neutral, sees ‘too many unknowns’
May 01
1:44pm ET
CVS Health downgraded to Neutral from Overweight at Cantor Fitzgerald
May 01
12:55pm ET
CVS Health Downgraded to Market Perform Amid MA Recovery Uncertainties and Margin Challenges
May 01
12:45pm ET
CVS Health downgraded to Market Perform from Outperform at Leerink
May 01
12:00pm ET
CVS Health falls -17.3%
May 01
10:01am ET
CVS Health falls -18.1%
May 01
9:55am ET
Buy Rating Maintained for CVS Health Amidst Short-Term Challenges with Long-Term Growth Outlook
May 01
9:55am ET
CVS Earnings: CVS Plunges as Q1 Results Disappoint, Lowers Outlook
May 01
9:47am ET
CVS Health falls -19.4%
Yesterday
1:20pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
May 14
10:00am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
May 13
5:00pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages CVS Health Corporation Investors to Inquire About Securities Class Action Investigation - CVS
May 10
1:30pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
May 10
8:48am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health Corporation - CVS
May 09
1:15pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
May 08
5:00am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
May 07
1:45pm ET
IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
May 06
3:30am ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
May 02
5:00pm ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
CVS Financials
Key terms
Ad Feedback
CVS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CVS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
